BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 15035852)

  • 1. Transcriptional response of T cells to IFN-alpha: changes induced in IFN-alpha-sensitive and resistant cutaneous T cell lymphoma.
    Tracey L; Spiteri I; Ortiz P; Lawler M; Piris MA; Villuendas R
    J Interferon Cytokine Res; 2004 Mar; 24(3):185-95. PubMed ID: 15035852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma.
    Tracey L; Villuendas R; Ortiz P; Dopazo A; Spiteri I; Lombardia L; Rodríguez-Peralto JL; Fernández-Herrera J; Hernández A; Fraga J; Dominguez O; Herrero J; Alonso MA; Dopazo J; Piris MA
    Am J Pathol; 2002 Nov; 161(5):1825-37. PubMed ID: 12414529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional program associated with IFN-alpha response of renal cell carcinoma.
    Banerjee D; Chadalavada RS; Bourdon V; Korkola JE; Motzer RJ; Chaganti RS
    J Interferon Cytokine Res; 2006 Mar; 26(3):156-70. PubMed ID: 16542138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression.
    Sun WH; Pabon C; Alsayed Y; Huang PP; Jandeska S; Uddin S; Platanias LC; Rosen ST
    Blood; 1998 Jan; 91(2):570-6. PubMed ID: 9427711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
    Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
    Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha induces transient upregulation of c-FLIP through NF-kappaB activation.
    Kanetaka Y; Hayashida M; Hoshika A; Yanase N; Mizuguchi J
    Exp Cell Res; 2008 Jan; 314(2):246-54. PubMed ID: 17988665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional annotation of IFN-alpha-stimulated gene expression profiles from sensitive and resistant renal cell carcinoma cell lines.
    Holko M; Williams BR
    J Interferon Cytokine Res; 2006 Aug; 26(8):534-47. PubMed ID: 16881864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
    Wong HK
    G Ital Dermatol Venereol; 2008 Dec; 143(6):375-83. PubMed ID: 19169210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma.
    Kiessling MK; Klemke CD; Kaminski MM; Galani IE; Krammer PH; Gülow K
    Cancer Res; 2009 Mar; 69(6):2365-74. PubMed ID: 19258503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional profiles predict disease outcome in patients with cutaneous T-cell lymphoma.
    Litvinov IV; Jones DA; Sasseville D; Kupper TS
    Clin Cancer Res; 2010 Apr; 16(7):2106-14. PubMed ID: 20233883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of clonality in cutaneous T cell lymphoma and associated diseases.
    Wood GS
    Ann N Y Acad Sci; 2001 Sep; 941():26-30. PubMed ID: 11594579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-alpha inhibits proliferation in human T lymphocytes by abrogation of interleukin 2-induced changes in cell cycle-regulatory proteins.
    Erickson S; Sangfelt O; Castro J; Heyman M; Einhorn S; Grandér D
    Cell Growth Differ; 1999 Aug; 10(8):575-82. PubMed ID: 10470857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma.
    Ellis L; Pan Y; Smyth GK; George DJ; McCormack C; Williams-Truax R; Mita M; Beck J; Burris H; Ryan G; Atadja P; Butterfoss D; Dugan M; Culver K; Johnstone RW; Prince HM
    Clin Cancer Res; 2008 Jul; 14(14):4500-10. PubMed ID: 18628465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of gene expression in hepatitis B virus transfected cell line induced by interferon.
    Xiong W; Wang X; Liu XY; Xiang L; Zheng LJ; Liu JX; Yuan ZH
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Dec; 35(12):1053-60. PubMed ID: 14673494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2.
    Leaman DW; Chawla-Sarkar M; Jacobs B; Vyas K; Sun Y; Ozdemir A; Yi T; Williams BR; Borden EC
    J Interferon Cytokine Res; 2003 Dec; 23(12):745-56. PubMed ID: 14769151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of myelo-monocytic My7 antigen (CD13) expression by interferon-alpha in basal cells of cutaneous T-cell lymphomas.
    Dreno B; Fleischmann M; Valard S; Godefroy W; Bureau B; Stadler JF; Litoux P
    Br J Dermatol; 1992 Apr; 126(4):320-3. PubMed ID: 1349233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
    Ferenczi K; Yawalkar N; Jones D; Kupper TS
    Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).
    Gu Z; Lee RY; Skaar TC; Bouker KB; Welch JN; Lu J; Liu A; Zhu Y; Davis N; Leonessa F; Brünner N; Wang Y; Clarke R
    Cancer Res; 2002 Jun; 62(12):3428-37. PubMed ID: 12067985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents.
    Sors A; Jean-Louis F; Bégué E; Parmentier L; Dubertret L; Dreano M; Courtois G; Bachelez H; Michel L
    Clin Cancer Res; 2008 Feb; 14(3):901-11. PubMed ID: 18245554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.